Department of Internal Medicine II-Cardiology, University of Ulm, Ulm, Germany.
Clin Res Cardiol. 2017 Aug;106(8):590-597. doi: 10.1007/s00392-017-1093-2. Epub 2017 Mar 10.
Predictors for the need of permanent pacemaker implantation (PPMI) in the context of transcatheter aortic valve implantation (TAVI) are not well defined yet. We evaluated the impact of conduction disturbances, calcium volume of the device landing zone, oversizing and implantation depth on PPMI after TAVI with the balloon-expandable Edwards Sapien 3 (ES3).
335 consecutive patients undergoing transfemoral TAVI with the ES3 for the treatment of symptomatic severe aortic stenosis were included (clinicaltrials NCT02162069). Rate of PPMI after TAVI was 18.4%, excluding patients with permanent pacemakers prior to TAVI or valve-in-valve implantations. Patients requiring PPMI more often had first degree atrioventricular block (AVB) at baseline (48.7 vs. 16.5%, p < 0.01), preprocedural complete right bundle branch block (RBBB; 25.0 vs. 3.9%, p < 0.01) and higher calcium volume of the aortic valve (258.5 ± 317.3 vs. 163.6 ± 178.8 mm³, p < 0.01). There was a trend towards higher rate of PPMI in patients with new-onset left bundle branch block after TAVI (32.7 vs. 20.7%, p = 0.06). Multivariate logistic regression analysis showed that baseline first degree AVB (odds ratio 3.9, 95% confidence interval 1.73-9.10, p < 0.01) and preprocedural complete RBBB (odds ratio 4.5, 95% confidence interval 1.50-13.21, p < 0.01) were independent predictors of PPMI. Of note, neither oversizing nor implantation depth were independent predictors for need of PPMI with the ES3.
In patients treated with the ES3 for symptomatic severe aortic stenosis first degree AVB and complete RBBB at baseline were independently associated with higher rates of postprocedural PPMI, whereas implantation depth and oversizing did not have an impact on PPMI.
经导管主动脉瓣置换术(TAVI)中永久性起搏器植入(PPMI)需求的预测因素尚未明确。我们评估了传导障碍、器械着陆区钙体积、球囊扩张型爱德华兹·萨皮恩 3 型(ES3)的器械超选和植入深度对 TAVI 后 PPMI 的影响。
335 例连续接受经股 TAVI 治疗症状性严重主动脉瓣狭窄的患者(临床试验 NCT02162069)。TAVI 后 PPMI 发生率为 18.4%,不包括 TAVI 前或瓣膜内植入有永久性起搏器的患者。需要 PPMI 的患者在基线时更常出现一度房室传导阻滞(AVB)(48.7% vs. 16.5%,p<0.01)、术前完全右束支阻滞(RBBB;25.0% vs. 3.9%,p<0.01)和更高的主动脉瓣钙体积(258.5±317.3 vs. 163.6±178.8mm³,p<0.01)。TAVI 后新发左束支传导阻滞患者的 PPMI 发生率呈上升趋势(32.7% vs. 20.7%,p=0.06)。多变量逻辑回归分析显示,基线一度 AVB(优势比 3.9,95%置信区间 1.73-9.10,p<0.01)和术前完全 RBBB(优势比 4.5,95%置信区间 1.50-13.21,p<0.01)是 PPMI 的独立预测因素。值得注意的是,ES3 中,器械超选和植入深度均不是 PPMI 的独立预测因素。
在接受 ES3 治疗症状性严重主动脉瓣狭窄的患者中,基线时一度 AVB 和完全 RBBB 与 TAVI 后更高的 PPMI 发生率独立相关,而植入深度和超选对 PPMI 没有影响。